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OBJECTIVES This study assessed the heart variability response to orthostatic stress during tilt table testing
before and after normal saline administration.
BACKGROUND The efficacy of sodium chloride and mineralocortoid in the treatment of neurally mediated
cardiac syncope is attributed to intravascular volume expansion; however, their modulation of
autonomic nervous system activity has not been evaluated.
METHODS Heart rate variability analysis was performed on 12 adolescents with a history of syncope or
presyncope (mean age 15.2 6 0.7 years) during tilt table testing. Subjects were upright 80° for
30 min or until syncope. After normal saline administration, the patient was returned upright
for 30 min. Heart rate variability analysis data were analyzed by an autoregression model
(Burg method).
RESULTS All subjects reproducibly developed syncope during control tilt table testing; median time to
syncope was 9.4 6 2.1 min. After normal saline infusion, none of the subjects developed
syncope after 30 min upright. In the control tilt, there was an initial increase followed by a
progressive decrease in low frequency power until syncope. Repeat tilt after normal saline
administration demonstrates that low frequency power increased but the magnitude of initial
change was blunted when compared with control. In addition, low frequency power increased
during normal saline tilt sequence compared with the control tilt, during which it decreased.
CONCLUSIONS Normal saline blunted low frequency power stimulation and prevented paradoxical low
frequency power (sympathetic) withdrawal. Increasing intravascular volume with normal
saline alters autonomic responses that may trigger neurally mediated syncope reflexes. (J Am
Coll Cardiol 1999;33:2059–66) © 1999 by the American College of Cardiology
Recurrent unexplained syncope is a common disorder af-
fecting children and adolescents, with up to 15% to 25% of
children experiencing at least one episode of syncope (1,2).
The most commonly accepted hypothesized mechanism for
neurally mediated cardiac syncope invokes dependent pool-
ing during orthostatic stress to produce effective hypovole-
mia, thereby activating the Bezold-Jarisch reflex and para-
doxically reducing sympathetic tone; the result is
vasodilation or bradycardia (3–5). Conversely, studies of
cardiac transplant patients suggest that ventricular receptor
activation may not be the exclusive cause of vasovagal
syncope (6–9). Nevertheless, in young patients with recur-
rent syncope, the passive head-up tilt (HUT) may be very
useful in suggesting a neurally mediated etiology and for
determining the efficacy of varied therapeutic interventions
(4). Indeed, HUT and other methods of orthostatic stress
(standing, lower body negative pressure) have been used
extensively in younger subjects in an attempt to understand
the pathophysiology of syncope (10–18).
The mechanism by which normal saline prevents syncope
is also not well elucidated. Although its efficacy has been
attributed to intravascular volume expansion, its effect upon
autonomic nervous system modulation during orthostatic
stress has not been evaluated. One hypothesis is that
restoration of intravascular volume blunts the sympathetic
stimulation responsible for increasing contractility and re-
duction in left ventricular cavity dimension, thereby obviat-
ing the elicitation of the Bezold-Jarisch reflex. However, it
is not clear the extent to which syncope is a function of
neural activity and the degree to which other factors—
humoral or paracrine—are involved (5).
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Spectral analysis of heart rate variability (HRV) provides
a simple noninvasive means for quantitative analysis of
cardiac sympathovagal tone (19–23). We wished to address
the following questions: How do changes in heart period
oscillations relate to clinical status—namely: 1) What are
the serial changes seen in low and high frequency power
during a HUT test terminating syncope? and 2) How does
administration of normal saline affect clinical status and the
resulting power–frequency distribution?
METHODS
Study group. Of 65 adolescents evaluated with a history of
at least one episode of syncope or presyncope, 12 (mean
15.2 6 0.7 years) had reproducible syncope by HUT,
without isoproterenol infusion, and formed our study group
(Table 1). Reproducible syncope for the purpose of this
study was defined as two consecutive HUT tests that
resulted in significant hypotension with/without bradycar-
dia. None displayed an cardioinhibitory form of neurally
mediated cardiac syncope. Except for two subjects, one with
mild aortic valvular insufficiency and the second with mild
mitral regurgitation, all others had normal heart structure by
two-dimensional echocardiography with Doppler interroga-
tion. Electrocardiograms for all subjects were normal, with
the corrected QT intervals ranging from 0.38 to 0.44. No
conduction abnormalities were demonstrated. Twenty-
four–hour Holter monitoring revealed no significant con-
duction or rhythm abnormalities. Two subjects had slightly
blunted blood pressure responses to graded exercise stress
testing, and two demonstrated poor aerobic capacities, but
otherwise had normal heart rate and blood pressure re-
sponses. The remainder of the subjects had normal tests.
Informed consent was obtained from all subjects before
HUT testing.
Head-up tilt protocol. The subjects received nothing per
os for 6 to 8 h before the study. An intravenous line was
placed for fluid administration. Under sterile conditions
with 1% lidocaine for local anesthesia, a 22-ga radial arterial
line was placed by the Seldinger technique in the left or
right radial artery for continuous blood pressure monitoring.
Electrocardiographic and blood pressure data were collected
with the Arrhythmia Research Technologies Cardio-Lab
computer system and stored on optical disk. After a 30-min
recovery period after vascular line placement, the patient
was elevated to 80° on an electrically driven tilt table with a
foot board for weight-bearing for 30 min or until syncope
occurred, after which the table was returned to the supine
position (24). After recovery in the supine position to
baseline heart rate and blood pressure, a second HUT was
performed. Then after a second recovery period in the
supine position, 1 liter of normal saline was administered
intravenously over 20 min. After completion of the saline
infusion, a third HUT test was conducted.
Heart rate variability analysis. Electrocardiographic data
were acquired and stored on analog cassette tape using a
Marquette Holter Recorder system, model 8500. The elec-
trocardiographic data were digitized on a SpaceLab
FT2000A Holter Analysis Workstation, transferred to a
Sun Workstation and analyzed using the MATLAB anal-
ysis software package. Operator-selected epochs, 1 to 5 min
in length, were selected for analysis to represent the follow-
ing five states: 1) supine baseline; 2) early upright tilt
(within the first few minutes); 3) midtilt (a few minutes
preceding syncope or severe symptoms or if no symptoms
Abbreviations and Acronyms
HF 5 high frequency
HRV 5 heart rate variability
HUT 5 head-up tilt
LF 5 low frequency
Table 1. Clinical Characteristics of Patients With Neurally Mediated Syncope
Patient
Age
(yr/mo) Gender
History of
Echocardiogram
Exercise
Stress Test ECG
Time to
SyncopeDizziness Syncope
1 14/1 F 1 0 Normal Normal Normal QTc 0.44 4 min
2 13/9 M 1 1 Mild AR Normal Normal QTc 0.38 2 min
3 17/4 F 1 0 Normal Normal Normal QTc 0.41 21 min
4 17/7 M 1 1 Mild MR/PR/TR Normal Normal QTc 0.41 20 min
5 16/8 F 1 1 Normal Normal Normal QTc 0.43 6 min
6 14/5 F 1 1 Normal Normal Normal QTc 0.41 18 min
7 14/9 F 1 1 Normal Normal Normal QTc 0.42 6 min
8 15/10 M 1 1 Normal Normal Normal QTc 0.41 3 min
9 9/3 M 1 1 Normal Normal Normal QTc 0.42 4 min
10 14/10 M 1 1 Normal Not performed Normal QTc 0.40 4 min
11 16/2 M 1 1 Normal Normal Normal QTc 0.38 17 min
12 18/1 F 1 1 Normal Normal Normal QTc 0.41 8 min
AR 5 aortic regurgitation; ECG 5 electrocardiogram; F 5 female; M 5 male; MR 5 mitral regurgitation; PR 5 pulmonary regurgitation; QTc 5 corrected QT interval; TR 5
tricuspid regurgitation; 1 5 present; 0 5 absent.
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developed, at about 15 min); 4) syncope, that is, during
severe symptoms or the last 5 min of a 30-min tilt, and 5)
supine recovery.
The program used operator-supplied parameters to auto-
matically detect QRS complexes; rarely occurring detection
failures could be corrected with overview and editing by
previously described methods (25). Histograms of RR
intervals for sinus beats were computed and pseudodigitized
at 10 samples/s for processing by conventional signal anal-
ysis algorithms. Autoregressive modeling (Burg method)
was used to construct frequency domain spectrograms of the
HRV (26). Heart rate period parameters extracted were low
frequency (LF) power (0.03 to 0.15 Hz), peak LF power,
high frequency (HF) power (0.16 to 0.50 Hz) and the ratio
of LF to HF power.
Statistics. Mean and standard error of the mean for the
parameters in each epoch are given in Table 2. A two-way
repeated measures analysis of variance (Proc GLM on
PC-SAS) (27) was used to identify significant treatment
and between-treatment effects. P values were adjusted by
the Huynh-Feldt criteria to account for asphericity. If
identified as significant, a Student-Newman-Keuls test was
applied to identify within-treatment significance. Signifi-
cance was defined at the 0.05 level.
RESULTS
Hemodynamic changes during HUT testing. During
both control studies, all 12 subjects experienced syncope,
associated with hemodynamic instability manifested pri-
marily as hypotension (systolic blood pressure 56 mm Hg 6
13). The mean time to syncope was 9.4 6 2.1 min (range 2
to 21 min). Figure 1 shows mean values and standard error
of the mean for heart rate and blood pressure for each stage
of the second control tilt sequence. Syncope was presaged by
a marked decrease in blood pressure (235.8 6 7.9 mm Hg,
p , 0.05) and accompanied by a decrease in heart rate
(231.2 6 5.5 beats/min, p , 0.05).
After saline infusion and 80° HUT, there was a small
decrease in blood pressure (early tilt to late tilt 5 216.5 6
6.2, p , 0.05) and a small increase in heart rate (early tilt to
late tilt 5 116.2 6 2.6 beats/min, p , 0.05). Despite
maintenance of the upright position for 30 min, all patients
remained without syncope (see Fig. 1, B). The initial
increase in heart rate during the transition from supine to
early tilt was significantly blunted. The heart rate increase
first became significant at the midtilt point (113.6 6 2.9
beats/min, p , 0.05) and continued to increase despite
maintenance of the upright position. Saline infusion mod-
ified the amplitude of the blood pressure response to tilt, as
well as the phase response of heart rate to tilt significantly
(p , 0.05).
Heart rate variability analysis. CONTROL STUDIES. A typ-
ical HRV sequence for a control tilt study is depicted as a
graph of power spectral density in Figure 2A. Initially
during early tilt there was a marked increase in the LF
power. Subsequently LF power decreased progressively, as
the upright position was maintained, until syncope oc-
curred. High frequency power changed in a reciprocal
manner.
In transition from the baseline supine position to early
tilt, LF power (134.3 6 6.6, p , 0.05), peak LF density
(11.30 6 0.25, p , 0.05) and LF/HF ratio (17.98 6 1.35,
p , 0.05) increased significantly, whereas from early tilt to
syncope, LF power (225.4 6 5.0, p , 0.05), peak LF
density (21.08 6 0.21, p , 0.05) and LF/HF ratio
(27.07 6 1.24, p , 0.05) decreased significantly. After
recovery in the supine position, these parameters returned to
their baseline values. Figure 3 depicts the tilt sequence for
these LF parameters.
Initial decreases upon tilt in HF (230.4 6 5.5, p , 0.05)
were significant. High frequency power increased signifi-
cantly (HF, 122.1 6 5.5, p , 0.05) from early tilt to
syncope.
SALINE INFUSION STUDIES. Figure 2B shows the HRV
sequence in a saline tilt study for the same patient as Figure
2, A. The moderate increase in LF power tended to be
maintained at about the same level throughout the upright
position.
In the saline studies, LF parameters initially increased
Table 2. Heart Rate Variability Analysis
Control Studies Saline Studies
Low frequency
power
Supine 45.2 6 5.6 Supine 47.3 6 4.5
Early tilt 77 6 1.8* Early tilt 68.8 6 2.6*
Midtilt 72.1 6 2.4 Midtilt 71.8 6 1.4
Faint/late tilt 51.6 6 5.3†‡ Late tilt 71.3 6 2.8
Recovery 41.4 6 3.7 Recovery 43 6 4.3
Peak LF density
Supine 0.89 6 0.18 Supine 0.83 6 0.1
Early tilt 2.19 6 0.16* Early tilt 1.56 6 0.12*
Midtilt 1.95 6 0.21 Midtilt 1.70 6 0.09
Faint/late tilt 1.11 6 0.15†‡ Late tilt 1.77 6 0.16
Recovery 0.72 6 0.11 Recovery 0.74 6 0.11
LF/HF ratio
Supine 1.87 6 0.57 Supine 1.57 6 0.34
Early tilt 9.84 6 1.32* Early tilt 5.49 6 1.17*
Midtilt 8.21 6 1.09 Midtilt 6.18 6 0.8
Faint/late tilt 2.77 6 0.93†‡ Late tilt 7.28 6 1.06
Recovery 1.25 6 0.3 Recovery 1.38 6 0.4
High frequency
power
Supine 40.2 6 6.1 Supine 39.9 6 4.6
Early tilt 9.7 6 1.3* Early tilt 17.5 6 2.6*
Midtilt 10.2 6 1.2 Midtilt 13.8 6 1.7
Faint/late tilt 31.8 6 5.5†‡ Late tilt 11.5 6 1.3
Recovery 45 6 4.7 Recovery 44.1 6 4.3
*p , 0.05, early tilt vs. supine; †p , 0.05, late tilt vs. early tilt; ‡p , 0.05, faint/late
tilt vs. midtilt.
HF 5 high frequency; LF 5 low frequency.
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from the supine to the early tilt state, that is, LF (122.5 6
4.4, p , 0.05), peak LF (10.73 6 0.11, p , 0.05) and
LF/HF (13.9 6 1.16, p , 0.05) (Fig. 3). After 30 min of
upright position further increases in LF parameters were not
significant.
The initial decrease in HF power (222.4 6 4.2, p ,
0.05) was significant. High frequency power remained low
during the upright position for 30 min and increased again
after recovery in the supine state.
COMPARISON OF CONTROL VERSUS SALINE INFUSION
STUDIES. Figure 1 reveals differences in the hemodynamic
changes between the control and saline studies. This differ-
ence was also reflected in corresponding changes in HRV
parameters. Figures 2A and B depict a typical example of
the differences observed in the HRV sequences between a
control and a saline study on the same patient, particularly
in the initial increase in LF. The same contrast of control
versus saline studies is apparent in Figure 3. Saline was
found to have a significant moderating effect on the re-
sponse of heart rate, blood pressure, LF power and HF
power during HUT (two-way analysis of variance, p ,
0.01).
We emphasize one other important observation. The
initial increase in LF parameters during the control studies
was greater than their initial increase in the saline studies,
for example, LF power (control 5 20.9 6 6.0 vs. saline 5
Figure 1. Heart rate and blood pressure changes during the control and saline tilt sequences. Heart rate increased markedly (A) and blood
pressure (B) decreased early during the control tilt. A significant decrease in blood pressure presaged syncope; this occurred first and was
subsequently accompanied by a significant decrease in heart rate. The hemodynamic changes were comparatively attenuated during the
saline tilt. A small increase in heart rate between the early tilt and late tilt period was observed. #p , 0.05, early tilt or midtilt vs. supine.
*p , 0.05, midtilt or late tilt vs. early tilt. 1p , 0.05 faint/late tilt vs. midtilt.
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15.2 6 4.4%, p 5 NS), peak LF density (control 5 1.3 6
0.25 vs. saline 5 0.73 6 0.11 normalized units, p , 0.05)
and LF/HF ratio (control 5 7.98 6 1.35 vs. saline 5
3.92 6 1.16, p , 0.05).
DISCUSSION
This study provides insight into the mechanism(s) by which
the autonomic nervous system modulates hemodynamic
responses to HUT testing in young patients who are
susceptible to recurrent vasodepressor syncope. Our meth-
odology allowed serial measurement of the changes in low
and high frequency power, reflective of sympathetic and
parasympathetic activity, respectively, during a tilt table
study.
In control tilt studies, serial HRV analysis revealed that
after an initial marked increase, LF power progressively
decreased. At the time of syncope, LF power further
diminished accompanied by a marked decrease in systolic
blood pressure, suggesting a paradoxical withdrawal of
sympathetic tone. After normal saline administration, auto-
nomic responses to tilt table testing were altered in two
important ways. First, the initial activation of LF power was
attenuated when compared with the control tilt table
sequence. In addition, after normal saline administration,
LF power progressively increased during prolonged ortho-
static stress, as opposed to the decrease noted during control
studies.
Autoregressive modeling for HRV spectra. Autoregres-
sive methods have been shown to produce better resolution
Figure 2. Power spectral density during control tilt (A) and saline tilt (B). During the control tilt, upon assumption of the upright position,
there was a significant increase in low frequency power (0.03 to 0.15 Hz) with a decrease in high frequency power (0.16 to 0.50 Hz).
Despite continued upright positioning, there was a progressive decline in low frequency power. After the administration of normal saline,
low frequency power progressively increased during the remainder of upright positioning.
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of sharp peaks in HRV spectra than the fast Fourier
transform; to make smoother, more interpretable curves,
and to illustrate the reciprocal nature of sympathovagal
balance (17,18,28). Moreover, shorter sampling periods of
heart rate data could be analyzed using the autoregression
algorithm compared to the fast Fourier transformation
method (29,30). This allowed selection of discrete time
epochs representing distinct physiologic states, preceding
and during syncope, and demonstration of dynamic changes
in autonomic nervous system activity with and without
therapeutic intervention in our study.
Heart rate variability and autonomic nervous activity.
Heart rate variability analysis provides a quantitative mea-
sure of sympathetic and parasympathetic autonomic nervous
activity; the relative contribution of each component to the
frequency spectra of heart rate variability has been the
subject of debate. The HF oscillations (0.15 to 0.50 Hz)
Figure 3. Low frequency (LF) power during control and saline tilt: A, LF power, B, peak LF power, and C, LF/high frequency (HF)
ratio. With upright tilt during the control state, there was a rapid and early peak in LF power. With continued upright positioning, a
progressive decrease in LF power was observed. However, after saline administration, LF power remained constant throughout the
duration of upright tilt. Solid line 5 control tilt; dashed line 5 saline tilt. #p , 0.05, early tilt vs. supine. *p , 0.05, faint/late tilt vs.
early tilt.
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represent parasympathetic vagal influences, closely related to
respiratory frequency, upon cardiac rhythmicity (19–23).
Akselrod et al. showed that animals undergoing parasym-
pathetic blockade with glycopyrrolate, a vagolytic agent,
experienced elimination of the HF component of HRV
(19).
Low frequency power (0.03 to 0.15 Hz) may represent
both sympathetic and parasympathetic autonomic influ-
ences (19,31). Moderate exercise, mental stress, transient
coronary artery occlusion and hemorrhage are associated
with increases in LF power (32–35). Hayoz et al. showed a
progressive withdrawal of muscle nerve sympathetic activity,
which was accompanied by a concomitant decrease in LF
power (36). Thus, it can be inferred that alterations in LF
power are principally dominated by changes in sympathetic
tone.
Previous studies of HRV and syncope. Previous studies of
syncope in young subjects using HRV spectra have shown a
shift from HF to LF power upon initial HUT, suggesting a
shift from parasympathetic to sympathetic chronotropic
control of the heart (17,18,23,37,38). In our study, the
decrease of HF power similarly suggested a shift from
parasympathetic control in the first few minutes of HUT.
Similar to two earlier studies, syncope or presyncope was
related to progressive withdrawal of LF power and a marked
decrease in blood pressure during prolonged orthostatis
(18,38). In our control studies, values for LF/HF ratio
during supine and HUT stages were very similar to those
found by Lagi et al. (18). High frequency power began to
increase again during syncope. Serial HRV analysis in our
study revealed that after an initial increase, all LF indexes
(LF power, peak LF power density, LF/HF ratio) progres-
sively decreased, accompanied by a marked decrease in
systolic blood pressure, presaging syncope. At the time of
syncope, LF indexes further diminished accompanied by a
moderate decrease in heart rate. These data indicate the
important role played by neural activity changes, but do not
obviate other possible factors such as humoral or paracrine
effects.
Some prior reports on neurally mediated syncope have
shown different results than ours for several reasons (36–
39). First, there is no standard procedure used to sequester
blood volume and elicit syncope (24); some studies have
used standing or lower body negative pressure, and others
have incorporated protocols using lesser degrees of HUT
maintained for longer times or isoproterenol administration
(24). Second, our population was adolescent, and their
physiology may not necessarily behave the same as older
adults (12,16,39). Third, some reports fail to distinguish
between vasodepressor and cardioinhibitory responses to
HUT; the respective mechanism underlying each may not
be quite the same (40). Last, our methodology allowed serial
measurement of the changes in LF and HF power, reflective
of distinct changes in sympathetic/parasympathetic activity
during a tilt table study.
Therapeutic considerations. Strategies to treat neurally
mediated syncope have included the following: administra-
tion of beta-adrenergic blocking agents such as esmolol and
metoprolol; administration of alpha-adrenergic agents such
as pseudoephedrine and midodrine, and administration of
mineralocorticoids with increased fluid and salt intake (41).
In this study, intravenous administration of normal saline
resulted in immediate volume expansion with amelioration
of syncope during repeat HUT. Previous studies by Fouad
et al. have demonstrated hypovolemia in this patient subset
(42). Long-term oral administration of sodium chloride also
has been shown to increase blood volume with concomitant
improvement in tolerance of orthostatis (14,43). Mangru et
al. have shown that saline infusion mitigated the hemody-
namic effects of neurocardiogenic syncope in 84% of their
cases and that those patients responding to saline infusion
did well with a high salt diet with/without oral mineralo-
corticoids (44).
Future research. The tenuous state of syncope-prone in-
dividuals, which apparently does not allow them to com-
pensate for normal postural changes, requires explanation.
The efficacy of sodium chloride supplementation and min-
eralocorticoid administration in preventing further episodes
of syncope suggests the possibility of defects in normal water
and sodium homeostasis of the body or in autonomic
vascular tone regulation. Hypoaldosteronism or aldosterone-
resistant conditions may exist which alter the homeostatic
state, preventing the body from adequately compensating
for orthostatic stress. Increased understanding of these
processes may allow for more directed therapies. Investiga-
tion of sodium and water regulation should be included in
future research.
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